Welcome to our press and media reel, here you will find the latest company updates, announcements and research materials.
-
Counting Stars: Why an Astrocentric Perspective Matters for CNS Drug Discovery
A new invited pharmaceutical industry editorial by Dr Nat Hastings, Cellestial’s CEO, has recently been published in IBI by SENGLOBAL LTD. 𝗪𝗵𝗮𝘁 𝘄𝗲 𝗹𝗲𝗮𝗿𝗻𝘁:✦ CNS…
-
IGJC 2026: What Heals the Mind, Heals the Heart Also
On 25-29th of July 2026, a world-leading group of experts in gap junctional biology came together in the halls of the historic University of Padua, Italy, at…
-
New Peer-Reviewed Research Paper: Protecting Overlooked Cells as a New Approach to Parkinson’s
10th of July 2026; Cambridge, UK A translational study published in Experimental Neurology suggests a new experimental therapeutic approach to slowing down Parkinson’s disease progression. The work,…
-
Cellestial Health Presents at the Venture Summit West, California
18th of June 2026; Mountain View, California, USACellestial Health, an innovative pharmaceutical development company offering a paradigm shift approach to Parkinson’s treatments, announces its selection…